Cancer is a complex deadly disease that has caused a global health crisis in recent epochs.
Colorectal cancer (CRC) is the third most common malignant gastrointestinal disease. It has …

Background: Molecules secreted by Trypanosoma cruzi (T. cruzi) have beneficial effects on
the immune system and can fight against cancer by inhibiting the growth of tumor cells …

Statement of Retraction We, the Editors and Publisher of the journal Bioengineered, have
retracted the following article: Zhipeng Jiang, Zehui Hou, Wei Liu, Zhuomin Yu, Zhiqiang …

Liver cancers are the fourth leading cause of cancer-related mortality worldwide. In the past
decade, breakthroughs in the field of artificial intelligence (AI) have inspired development of …

Purpose Nearly 50% of patients recur within two years after curatively intended resection of
colorectal cancer liver metastasis (CRLM). The optimal surveillance strategy is unknown due …

Colorectal cancer (CRC) liver metastasis is a significant clinical problem for which better
therapies are urgently needed. Tumor-associated macrophage, a major cell population in …

Liver metastasis is a leading cause of cancer morbidity and mortality. Thus, there has been
strong interest in the development of therapeutics that can effectively prevent liver …

Colorectal cancer (CRC) is the second leading cause of cancer deaths worldwide. Stage IV
CRC patients have poor prognosis with a five-year survival rate of 14%. Liver metastasis is …

The recurrence rate of colorectal liver metastases (CRLM) patients treated with curative
intent is above 50%. Standard of care surveillance includes intensive computed …

Colorectal cancer (CRC) remains one of the most aggressive and lethal cancers, with
metastasis accounting for most deaths. As such, there is an unmet need for improved …